Are We There Yet? Recent Progress in the Molecular Diagnosis and Novel Antifungal Targeting of and Invasive Aspergillosis

English version České info

Vyšlo v časopise: Are We There Yet? Recent Progress in the Molecular Diagnosis and Novel Antifungal Targeting of and Invasive Aspergillosis. PLoS Pathog 9(10): e32767. doi:10.1371/journal.ppat.1003642
Kategorie: Pearls
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003642

Souhrn

Zdroje

1. GuoYL, ChenYQ, WangK, QinSM, WuC, et al. (2010) Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest 138: 817–824.

2. LamothF, CrucianiM, MengoliC, CastagnolaE, LortholaryO, et al. (2012) β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin Infect Dis 54: 633–643.

3. ThortonCR (2008) Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol 15: 1095–1105.

4. HeldJ, SchmidtT, ThorntonCR, KotterE, BertzH (2013) Comparison of a novel Aspergillus lateral-flow device and the Platelia galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation. Infection E-pub ahead of print. doi:10.1007/s15010-013-0472-5

5. ShiLN, LiFQ, LuJF, KongXX, WangSQ, et al. (2012) Antibody specific to thioredoxin reductase as a new biomarker for serodiagnosis of invasive aspergillosis in non-neutropenic patients. Clin Chim Acta 413: 938–943.

6. WhitePL, MengoliC, BretagneS, Cuenca-EstrellaM, FinnstromN, et al. (2011) Evaluation of Aspergillus PCR protocols for testing serum specimens. J Clin Microbiol 49: 3842–3848.

7. ZhaoY, ParkS, WarnP, ShriefR, HarrisonE, et al. (2010) Detection of Aspergillus fumigatus in a rat model of invasive pulmonary aspergillosis by real-time nucleic acid sequence-based amplification. J Clin Microbiol 48: 1378–1383.

8. WhitePL, PerryMD, MoodyA, FollettSA, MorganG, et al. (2011) Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive aspergillosis. J Clin Microbiol 49: 2169–2174.

9. Abad-Diaz-De-CerioA, Fernandez-MolinaJV, Ramirez-GarciaA, SendinoJ, HernandoFL, et al. (2013) The aspHS gene as a new target for detecting Aspergillus fumigatus during infections by quantitative real-time PCR. Med Mycol 51: 545–554.

10. SekonyelaR, PalmerJM, BokJ-W, JainS, BerthierE, et al. (2013) RsmA regulates Aspergillus fumigatus gliotoxin cluster metabolites including cyclo(L-Phe-L-Ser), a potential new diagnostic marker for invasive aspergillosis. PLoS ONE 8: e62591 doi:10.1371/journal.pone.0062591

11. PetrikM, FranssenGM, HaasH, LavermanP, HörtnaglC, et al. (2012) Preclinical evaluation of two 68Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging. Eur J Nucl Med Mol Imaging 39: 1175–1183.

12. WangY, ChenL, LiuX, ChengD, LiuG, et al. (2013) Detection of Aspergillus fumigatus pulmonary fungal infections in mice with (99m)Tc-labeled MORF oligomers targeting ribosomal RNA. Nucl Med Biol 40: 89–96.

13. HerbrechtR, DenningDW, PattersonTF, BennettJE, GreeneRE, et al. (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347: 408–415.

14. Marr KA, Schlamm H, Rottinghaus ST, Jagannatha S, Bow EJ, et al.. (2012) A randomised, double-bind study of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherpay for primary treatment of invasive aspergillosis; 22nd European Congress of Clinical Microbiology and Infectious Diseases, March 31–April 3, 2012; London. Abstract LB2812.

15. AlbarragAM, AndersonMJ, HowardSJ, RobsonGD, WarnPA, et al. (2011) Interrogation of related clinical pan-azole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A, upregulation of cyp51A, and integration and activation of transposon Atf1 in the cyp51A promoter. Antimicrob Agents Chemother 55: 5113–5121.

16. Van Der LindenJW, WarrisA, VerweijPE (2011) Aspergillus species intrinsically resistant to antifungal agents. Med Mycol 49 (suppl 1) S82–89.

17. JuvvadiPR, GehrkeC, FortwendelJR, LamothF, SoderblomEJ, et al. (2013) Phosphorylation of calcineurin at a novel serine-proline rich region orchestrates hyphal growth and virulence in Aspergillus fumigatus. PLoS Pathog 9: e1003564 doi:10.1371/journal.ppat.1003564

18. LamothF, JuvvadiPR, GehrkeC, AsfawYG, SteinbachWJ (2013) Transcriptional activation of heat-shock protein 90 (Hsp90) mediated via a proximal promoter region confers caspofungin resistance in Aspergillus fumigatus. J Infect Dis In press.

19. FengX, KrishnanK, RichieDL, AimaniandaV, HartlL, et al. (2011) HacA-independent functions of the ER stress sensor IreA synergize with the canonical UPR to influence virulence traits in Aspergillus fumigatus. PLoS Pathog 7: e1002330 doi:10.1371/journal.ppat.1002330

20. Ben-AmiR, AlbertND, LewisRE, KontoyiannisDP (2013) Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis. J Infect Dis 207: 1066–1074.

21. WillgerSD, PuttikamonkulS, KimK-H, BurrittJB, GrahlN, et al. (2008) A sterol-regulatory element binding protein is required for cell polarity, hypoxia adaptation, azole drug resistance, and virulence in Aspergillus fumigatus. PLoS Pathogens 4: e1000200 doi:10.1371/journal.ppat.1000200